寻常型天疱疮与血液系统恶性肿瘤的关联:基于11,859例人群研究
该横断面研究比较1,985例天疱疮患者与9,874例年龄、性别、族裔匹配对照的6种血液恶性肿瘤患病率。天疱疮组慢性白血病、多发性骨髓瘤和非霍奇金淋巴瘤患病率显著更高,慢性白血病关联在调整免疫抑制治疗后仍显著,其他类型无显著关联。
要点
- 天疱疮患者慢性白血病患病率0.9% vs 0.4%,OR 2.1(95%CI 1.2-3.6)。
- 多发性骨髓瘤患病率0.8% vs 0.4%,OR 2.2(95%CI 1.2-3.9)。
- 非霍奇金淋巴瘤患病率1.8% vs 1.2%,OR 1.5(95%CI 1.0-2.2)。
核心结论
- 天疱疮与慢性白血病、多发性骨髓瘤和非霍奇金淋巴瘤存在显著关联。
- 慢性白血病关联在调整免疫抑制治疗后仍显著(调整OR 2.0,95%CI 1.1-3.7)。
研究设计与样本
- 横断面研究,比较天疱疮患者与年龄、性别、族裔匹配对照的6种血液恶性肿瘤患病率。
- 纳入1,985例天疱疮患者和9,874例对照。
主要发现
- 慢性白血病患病率0.9% vs 0.4%,OR 2.1(95%CI 1.2-3.6)。
- 多发性骨髓瘤患病率0.8% vs 0.4%,OR 2.2(95%CI 1.2-3.9)。
- 非霍奇金淋巴瘤患病率1.8% vs 1.2%,OR 1.5(95%CI 1.0-2.2)。
- 急性白血病、霍奇金淋巴瘤、骨髓增生异常综合征和真性红细胞增多症与天疱疮无显著关联。
关键数值与推荐
- 慢性白血病:OR 2.1(95%CI 1.2-3.6),调整免疫抑制治疗后调整OR 2.0(95%CI 1.1-3.7)。
- 多发性骨髓瘤:OR 2.2(95%CI 1.2-3.9)。
- 非霍奇金淋巴瘤:OR 1.5(95%CI 1.0-2.2)。
临床怎么用
- 对天疱疮患者应关注慢性白血病、多发性骨髓瘤和非霍奇金淋巴瘤的筛查与监测。
局限性
- 天疱疮诊断缺乏免疫病理学验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The association of nonparaneoplastic pemphigus with comorbid hematologic malignancies has yet to be established. OBJECTIVE: To estimate the association between pemphigus and the common types of hematologic malignancies. METHODS: A cross-sectional study was conducted comparing pemphigus patients with age-, sex- and ethnicity-matched control subjects regarding the prevalence of 6 comorbid hematologic malignancies. The study was performed using the computerized database of Clalit Health Services ensuring the availability of 4.5 million patients. RESULTS: The study included 1985 pemphigus patients and 9874 control subjects. The prevalence of chronic leukemia (0.9% vs 0.4%, odds ratio [OR] 2.1, 95% confidence interval [CI] 1.2-3.6), multiple myeloma (0.8% vs 0.4%, OR 2.2, 95% CI 1.2-3.9), and non-Hodgkin lymphoma (1.8% vs 1.2%, OR 1.5, 95% CI 1.0-2.2) was greater in patients with pemphigus than in controls. The association with chronic leukemia remained significant following the adjustment for immunosuppressive therapy (adjusted OR 2.0, 95% CI 1.1-3.7). No significant associations were observed between pemphigus and acute leukemia, Hodgkin lymphoma, myelodysplastic syndrome, and polycythemia vera. LIMITATIONS: Lack of immunopathologic validation of the diagnosis of pemphigus. CONCLUSION: A significant association was observed between pemphigus and chronic leukemia, multiple myeloma, and non-Hodgkin lymphoma. Further research is warranted to establish this observation in other cohorts.
引用
- Kridin K, Zelber-Sagi S, Comaneshter D, et al. Pemphigus and hematologic malignancies: A population-based study of 11,859 patients. J Am Acad Dermatol. 2017. PMID: 29198780. doi:10.1016/j.jaad.2017.11.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。